Siste forsøk

EudraCT Number: 2004-001729-11

Sponsor Protocol Number: CR040301

Start Date: 2005-02-18

Sponsor Name: EBEWE Pharma Ges.m.b.H Nfg.KG

Full Title: A prospective, randomised, placebo controlled, double blind trial about safety and efficacy of combined treatment with Alteplase (rt-PA) and Cerebrolysin in acute ischemic hemispheric stroke

Medical condition: Clinical diagnosis of ischemic stroke causing a measurable neurological deficit defined as impairment of language, motor function, cognition and/or gaze, vision or neglect. Ischemic stroke is defin...

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.0		10055221		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Completed) SK (Completed) CZ (Completed) SI (Completed)

Trial results: View results

EudraCT Number: 2004-002165-20

Sponsor Protocol Number: 20040110

Start Date: 2005-02-18

Sponsor Name: Amgen Inc

Full Title: An open label study of AMG 706 in subjects with advanced gastrointestinal stromal tumors (GISTs) who developed progressive disease or relapsed while on Imatinib Mesylate.

Medical condition: Gastrointestinal stromal tumour (GIST)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) DE (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-002798-21

Sponsor Protocol Number: WI18273

Start Date: 2005-02-18

Sponsor Name: F.Hoffmann-La Roche Ltd

Full Title: A Phase II, prospective, randomized, double-blind, active-controlled, parallel group, multi-center 'proof of concept' trial in adult patients with community-acquired pneumonia requiring hospitaliza...

Medical condition: Community-acquired pneumonia

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LV (Completed) HU (Completed) SK (Completed) LT (Completed)

Trial results: View results

EudraCT Number: 2004-005045-35

Sponsor Protocol Number: CLAF237A2327

Start Date: 2005-02-17

Sponsor Name: Novartis Sverige AB

Full Title: A multicenter, randomized, double-blind, active controlled study to compare the effect of 24 weeks treatment with LAF237 50 mg bid to rosiglitazone 8 mg qd in drug naïve patients with type 2 diabetes

Medical condition: Type II Diabetes

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed)

Trial results: View results

EudraCT Number: 2004-002102-30

Sponsor Protocol Number: CC-5013-MM-012

Start Date: 2005-02-17

Sponsor Name: CELGENE EUROPE LIMITED

Full Title: OPEN-LABEL, SINGLE-ARM STUDY OF THE SAFETY AND EFFICACY OF CC-5013 MONOTHERAPY FOR SUBJECTS WITH MULTIPLE MYELOMA A COMPANION STUDY FOR STUDIES THAL-MM-003, CC-5013-MM-009, AND CC-5013-MM-010

Medical condition: Multiple Myeloma

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10028228	Multiple myeloma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-003761-33

Sponsor Protocol Number: IDT.ES.LEV.12004-EMDE

Start Date: 2005-02-17

Sponsor Name: Unidad de Neuroinmunología

Full Title: Unicenter double-blind, cross-over, randomised, placebo controlled clinical trial to evaluate efficacy of vardenafil in subjects with E.D. and multiple sclerosis (M.S.)

Medical condition: Erectile Dysfunction

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2004-002633-39

Sponsor Protocol Number: SHCS-Projekt Nr. 408

Start Date: 2005-02-17

Sponsor Name: Prof. Dr. med. Milos Opravil, Universitätsspital Zürich

Full Title: Prospective study of switch to 3TC monotherapy with evaluation of replication capacity in patients with virologic failure and 3TC resistance (a multicenter prospective clinical study within the SH...

Medical condition: HIV patients with virological treatment failure due to multi-drug-resistant virus including 3TC resistance

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-001845-13

Sponsor Protocol Number: Y-47-52120-722

Start Date: 2005-02-17

Sponsor Name: Beaufour Ipsen Pharma S.A.S.

Full Title: A phase II, multicentre, multinational, prospective, randomised, double-blind, placebo controlled study assessing the efficacy and safety of a single application of three doses of Dysport in patien...

Medical condition: Upper back myofascial pain syndrome (MPS)

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10048780		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed) GB (Completed) CZ (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-004130-14

Sponsor Protocol Number: IMA 04001

Start Date: 2005-02-17

Sponsor Name: Biogen Idec GmbH

Full Title: A multicenter, randomized, rater-blind study to compare the efficacy and safety of natalizumab (300 mg IV every four weeks) with Interferon beta-1a (44 mcg SC three times a week) in subjects with r...

Medical condition: Male and female subjects with relapsing multiple sclerosis previously treated with interferon beta-1a (22 mcg or 44 mcg, SC three times a week).

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: AT (Completed)

Trial results: View results

EudraCT Number: 2004-001862-42

Sponsor Protocol Number: MeBN/02/Zof-AMI/001

Start Date: 2005-02-17

Sponsor Name: Clinical Research Facilities

Full Title: A multicenter, double-blind, randomized 2x2 factorial design study to compare the efficacy of early (

Medical condition: Study population: Subjects undergoing a primary percutaneous coronary intervention (PCI) to be performed within 6 hours after the onset of symptoms of a first acute anterior myocardial infarction ...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IE (Completed)

Trial results: View results

Siste forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner